Imugene Limited (IMU.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3350-0.0150 (-4.29%)
At close: 4:10PM AEST
| Previous close | 0.3500 |
| Open | 0.3450 |
| Bid | 0.3350 x 102397000 |
| Ask | 0.3400 x 716752400 |
| Day's range | 0.3350 - 0.3500 |
| 52-week range | 0.0450 - 0.4950 |
| Volume | 5,079,255 |
| Avg. volume | 23,577,794 |
| Market cap | 1.672B |
| Beta (5Y monthly) | 2.16 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0030 |
| Earnings date | 23 Apr 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Imugene Licenses Cd19 Oncolytic Virus From City of Hope to Turn Car T Therapy Against Solid Tumors
City of Hope and Imugene have entered into a licensing agreement for the patents covering a novel combination immunotherapy.
- Simply Wall St.
Announcing: Imugene (ASX:IMU) Stock Soared An Exciting 946% In The Last Five Years
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
- Simply Wall St.
What Can We Learn About Imugene's (ASX:IMU) CEO Compensation?
Leslie Chong became the CEO of Imugene Limited (ASX:IMU) in 2016, and we think it's a good time to look at the...
© 2021 Verizon Media. All rights reserved.
